Página principal > Resultados de la búsqueda: Czerwiński, E.
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
8 p, 192.2 KB Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates / Miller, P.D. (Colorado Center for Bone Research) ; Pannacciulli, N. (Amgen Inc) ; Brown, J.P. (Laval University) ; Czerwinski, E. (Krakow Medical Center) ; Nedergaard, B.S. (Center for Clinical and Basic Research) ; Bolognese, M.A. (Bethesda Health Research Center) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Bone, H.G. (Michigan Bone and Mineral Clinic) ; Reginster, J. Y. (University of Liège) ; Singer, A. (Georgetown University Medical Center) ; Wang, C. (Amgen Inc) ; Wagman, R.B. (Amgen Inc) ; Cummings, S.R. (California Pacific Medical Center Research Institute) ; Universitat Autònoma de Barcelona
Denosumab and zoledronic acid (ZOL) are parenteral treatments for patients with osteoporosis. The objective of the study was to compare the effect of transitioning from oral bisphosphonates to denosumab or ZOL on bone mineral density (BMD) and bone turnover. [...]
2016 - 10.1210/jc.2016-1801
The journal of clinical endocrinology & metabolism, Vol. 101 Núm. 8 (august 2016) , p. 3163-3170  
Registro completo - Creative Commons
2.
8 p, 424.3 KB Relationship Between Bone Mineral Density T -Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment / Ferrari, Serge (Geneva University Hospitals (Suïssa)) ; Libanati, Cesar (UCB Pharma) ; Fang Lin, Celia Jow (Amgen Inc) ; Brown, Jacques P. (Laval University and CHU de Québec Research Centre) ; Cosman, Felicia (Columbia University) ; Czerwiński, Edward (Krakow Medical Center) ; de Gregόrio, L. H. (Center for Clinical and Basic Research - Brasil) ; Malouf Sierra, Jorge 1971- (Universitat Autònoma de Barcelona) ; Reginster, Jean-Yves (University of Liège) ; Wang, Andrea T. (Amgen Inc) ; Wagman, Rachel B. (Amgen Inc) ; Lewiecki, E. Michael (New Mexico Clinical Research & Osteoporosis Center)
Although treat-to-target strategies are being discussed in osteoporosis, there is little evidence of what the target should be to reduce fracture risk maximally. We investigated the relationship between total hip BMD T -score and the incidence of nonvertebral fracture in women who received up to 10 years of continued denosumab therapy in the FREEDOM (3 years) study and its long-term Extension (up to 7 years) study. [...]
2019 - 10.1002/jbmr.3722
Journal of Bone and Mineral Research, Vol. 34 (may 2019) , p. 1033-1040  
Registro completo - Creative Commons

Vea también: autores con nombres similares
2 Czerwinski, E.
1 Czerwiński, Edward
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos